Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin

Eight pediatric patients with acute lymphoblastic leukemia (ALL) were treated with intermediate‐dose cytosine arabinoside (ID‐AraC, 1 g/m2) in combination with adriamycin except one patient. Of the eight patients, four refractory to the initial induction therapy and one in bone marrow relapse gained...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical and pediatric oncology 1986, Vol.14 (2), p.73-77
Hauptverfasser:	Ishii, Eiichi, Hara, Toshiro, Ohkubo, Kenshi, Matsuzaki, Akinobu, Takeuchi, Takami, Veda, Kohji
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Bone Marrow - drug effects Brain Neoplasms - drug therapy Chemotherapy Child cytarabine Cytarabine - administration & dosage Cytarabine - metabolism doxorubicin Doxorubicin - administration & dosage Drug Administration Schedule Female Humans Infant Kinetics leukemia Leukemia, Lymphoid - drug therapy Leukocyte Count lymphoblastic Male Medical sciences Pharmacology. Drug treatments Platelet Count
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!